Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| University of Eastern Finland | OTHER |
| Finnish Medicines Agency | UNKNOWN |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The objective of this pragmatic multi-center randomized controlled trial is to test the effectiveness of interprofessional medication assessment in older patients needing home care due to their diseases or decreased functional capacity in primary care. The main hypothesis is that intervention has a positive impact on functional capacity and for rational and safe use of medicines.
Aging increases the risk of adverse effects and interactions caused by medication. Medication reconciliation and medication review are well-known practices to optimize medicines use. Both interventions usually require a team-based approach to be effective. Medication reconciliation is the process of obtaining and documenting a complete and accurate list of current patient medications and comparing this list with medication orders at each point of care transition to identify and rectify any discrepancies before patient harm occurs. Medication review is the process of evaluating current medication treatment to manage the risk and optimize the outcomes of medication treatment by detecting, solving, and preventing medication-related problems. The present study focuses on medication assessment including both medication reconciliation and review combined to clinical assessment of an individual patient.
According to a systematic review there is a need for research focusing on medication management in community settings and especially to assess the impact of medication assessment on clinical outcomes.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Active comparator | Active Comparator | In addition to usual care, participants allocated to intervention group will receive medication assessment and treatment plan based on it |
|
| Usual care | No Intervention | Usual care (reference group). |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Medication assessment and treatment plan based on it | Other | Intervention
|
| Measure | Description | Time Frame |
|---|---|---|
| Functional capacity IADL (Instrumental Activities of Daily Living) | at 6 months from baseline | |
| Functional capacity ADL (Activities of daily living;KATZ) | at 6 months from baseline | |
| Functional capacity TUG (Timed up and go) | at 6 months from baseline | |
| Functional capacity MMSE ( Mini-mental state examination) | at 6 months from baseline | |
| Functional capacity GDS (Geriatric Depression Scale)-15 | at 6 months from baseline |
| Measure | Description | Time Frame |
|---|---|---|
| Use of health care services | visits to physician, hospital days and nursing care at home | at 6 and 12 months from baseline |
| Need of services delivered to home | at 6 and 12 months from baseline |
Not provided
Inclusion Criteria:
Home dwelling ≥65 years-old persons registered to public home care services and who
Exclusion Criteria:
Home care is not responsible for patient's medication, for example due to severe chronic illness (for example severe renal insufficiency or cancer with active treatment in secondary or tertiary care).
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Pekka Mäntyselkä, MD | Professor | Study Chair |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Welfare district of Forssa | Forssa | FI 30100 | Finland | |||
| Selänne Basic Health Care District |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 33023497 | Derived | Auvinen K, Voutilainen A, Jyrkka J, Lonnroos E, Mantyselka P. Interprofessional medication assessment among home care patients: any impact on functioning? Results from a randomised controlled trial. BMC Geriatr. 2020 Oct 6;20(1):390. doi: 10.1186/s12877-020-01796-1. |
Not provided
Not provided
| Type | Date | Date Unknown |
|---|---|---|
| Release | Nov 1, 2017 | |
| Reset | Aug 17, 2018 |
Not provided
Not provided
| Release Date | Unrelease Date | Unrelease Date Unknown | Reset Date | MCP Release Number |
|---|---|---|---|---|
| Nov 1, 2017 | Aug 17, 2018 |
Not provided
Not provided
Not provided
Not provided
Not provided
|
| Number of medicines | at 6 and 12 months from baseline |
| Quality of medicines | at 6 and 12 months from baseline |
| Cost of medicines | at 6 and 12 months from baseline |
| Health related quality of life assessed with EQ-5D | at 6 and 12 months from baseline |
| Haapajärvi |
| FI 85800 |
| Finland |
| Juva Health Care | Juva | FI-51900 | Finland |
| City of Lahti, home care | Lahti | FI-15100 | Finland |
| Eastern Savo Hospital District | Savonlinna | FI-57100 | Finland |